Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India

• Petros Isaakidis ,

  * E-mail: msfocb-asia-epidemio@brussels.msf.org

  Affiliation Médecins Sans Frontières, Mumbai, India

  ⨯
• Bhanumati Varghese,

  Affiliation Médecins Sans Frontières, Mumbai, India

  ⨯
• Homa Mansoor,

  Affiliation Médecins Sans Frontières, Mumbai, India

  ⨯
• Helen S. Cox,

  Affiliations Médecins Sans Frontières, South African Medical Unit (SAMU), Cape Town, South Africa, University of Cape Town, Cape Town, South Africa

  ⨯
• Joanna Ladomirska,

  Affiliation Médecins Sans Frontières, Mumbai, India

  ⨯
• Peter Saranchuk,

  Affiliation Médecins Sans Frontières, South African Medical Unit (SAMU), Cape Town, South Africa

  ⨯
• Esdras Da Silva,

  Affiliation Médecins Sans Frontières, Mumbai, India

  ⨯
• Samsuddin Khan,

  Affiliation Médecins Sans Frontières, Mumbai, India

  ⨯
• Roma Paryani,

  Affiliation Médecins Sans Frontières, Mumbai, India

  ⨯
• Zarir Udwadia,

  Affiliation Parmanand Deepchand Hinduja National Hospital and Medical Research Centre (Hinduja), Mumbai, India

  ⨯
• Giovanni Battista Migliori,

  Affiliation World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy

  ⨯
• Giovanni Sotgiu,

  Affiliation Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, Sassari, Italy

  ⨯
• Tony Reid

  Affiliation Médecins Sans Frontières, Operational Research Unit, Brussels, Belgium

  ⨯